FULC (STOCKS)
Fulcrum Therapeutics, Inc. Common Stock
$3.489800
+0.039800 (+1.15%)
Prev close: $3.450000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Alexander C. Sapir
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $233.22M
- Employees
- 45
- P/E (TTM)
- -3.06
- P/B (TTM)
- 0.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.25 | $-0.30 | +0.0541 | +17.79% |
|
Dec 2025 (Q4)
|
$-0.31 | $-0.32 | +0.0053 | +1.68% |
|
Sep 2025 (Q3)
|
$-0.31 | $-0.30 | -0.0104 | -3.47% |
|
Jun 2025 (Q2)
|
$-0.28 | $-0.30 | +0.0158 | +5.34% |
Financial Statements
| Assets | $346.77M |
| Current Assets | $338.67M |
| Noncurrent Assets | $8.10M |
| Fixed Assets | $2.49M |
| Other Non-current Assets | $5.61M |
| Liabilities | $13.47M |
| Current Liabilities | $9.86M |
| Accounts Payable | $2.45M |
| Wages | $2.58M |
| Other Current Liabilities | $4.83M |
| Noncurrent Liabilities | $3.60M |
| Equity | $333.30M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $333.30M |
| Liabilities And Equity | $346.77M |